Bilal Nadeem
Overview
Explore the profile of Bilal Nadeem including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
112
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Azari F, Zhang K, Kennedy G, Bou-Samra P, Chang A, Nadeem B, et al.
Eur J Nucl Med Mol Imaging
. 2023 Mar;
50(8):2453-2465.
PMID: 36905412
Purpose: Pafolacianine, a folate receptor alpha-targeted NIR tracer, has demonstrated clear efficacy in intraoperative molecular imaging-guided (IMI) lung cancer surgery. However, the selection of patients who would benefit from IMI...
2.
Single-institution experience of 500 pulmonary resections guided by intraoperative molecular imaging
Kennedy G, Azari F, Chang A, Nadeem B, Bernstein E, Segil A, et al.
J Thorac Cardiovasc Surg
. 2023 Mar;
165(6):1928-1938.e1.
PMID: 36863974
Objective: Intraoperative molecular imaging (IMI) using tumor-targeted optical contrast agents can improve thoracic cancer resections. There are no large-scale studies to guide surgeons in patient selection or imaging agent choice....
3.
Azari F, Meijer R, Kennedy G, Hanna A, Chang A, Nadeem B, et al.
JAMA Netw Open
. 2023 Jan;
6(1):e2252885.
PMID: 36705924
Importance: Localization of subcentimeter ground glass opacities during minimally invasive thoracoscopic lung cancer resections is a significant challenge in thoracic oncology. Intraoperative molecular imaging has emerged as a potential solution,...
4.
Azari F, Kennedy G, Chang A, Nadeem B, Bou-Samra P, Chang A, et al.
Mol Imaging Biol
. 2022 Dec;
25(3):569-585.
PMID: 36534331
Background: Intraoperative molecular imaging (IMI)-guided resections have been shown to improve oncologic outcomes for patients undergoing surgery for solid malignancies. The technology utilizes fluorescent tracers targeting cancer cells without the...
5.
Azari F, Zhang K, Kennedy G, Chang A, Nadeem B, Delikatny E, et al.
J Nucl Med
. 2022 Aug;
63(11):1620-1627.
PMID: 35953303
Intraoperative molecular imaging (IMI) has recently emerged as an important tool in the armamentarium of surgical oncologists. IMI allows real-time assessment of oncologic resection quality, margin assessment, and occult disease...
6.
Kennedy G, Azari F, Nadeem B, Chang A, Segil A, Bernstein E, et al.
Mol Imaging
. 2022 Jul;
2022:5447290.
PMID: 35903245
Background: Early detection and complete resection are important prognostic factors for esophageal cancer (EC). Intraoperative molecular imaging (IMI) using tumor-targeted tracers is effective in many cancer types. However, there are...
7.
Azari F, Kennedy G, Chang A, Nadeem B, Sullivan N, Marfatia I, et al.
Eur J Nucl Med Mol Imaging
. 2022 Jul;
49(13):4406-4418.
PMID: 35876868
Background: Intraoperative molecular imaging (IMI) with folate-targeted NIR tracers has been shown to improve lesion localization in more than 80% of lung adenocarcinomas. However, mucinous adenocarcinomas (MAs) and invasive mucinous...
8.
Kennedy G, Azari F, Chang A, Nadeem B, Bernstein E, Segil A, et al.
Ann Surg
. 2022 Jul;
276(4):711-719.
PMID: 35837887
Background: Intraoperative molecular imaging (IMI) using tumor-targeted optical contrast agents can improve cancer resections. The optimal wavelength of the IMI tracer fluorophore has never been studied in humans and has...
9.
Kennedy G, Holt D, Azari F, Bernstein E, Nadeem B, Chang A, et al.
Clin Cancer Res
. 2022 Jul;
28(17):3729-3741.
PMID: 35792882
Purpose: Fluorescence-guided surgery using tumor-targeted contrast agents has been developed to improve the completeness of oncologic resections. Quenched activity-based probes that fluoresce after covalently binding to tumor-specific enzymes have been...
10.
Kennedy G, Azari F, Bernstein E, Nadeem B, Chang A, Segil A, et al.
Eur J Nucl Med Mol Imaging
. 2022 Jul;
49(12):4194-4204.
PMID: 35788703
Background: The diagnostic yield of biopsies of solitary pulmonary nodules (SPNs) is low, particularly in sub-solid lesions. We developed a method (NIR-nCLE) to achieve cellular level cancer detection during biopsy...